Loss of Heterozygosity Predicts Poor Survival After Resection of Pancreatic Adenocarcinoma

Background American Joint Committee on Cancer (AJCC) staging for pancreatic adenocarcinoma is a validated predictor of prognosis but insufficiently discriminates postresection survival. We hypothesized that genetic analysis of resected cancers would correlate with tumor biology and postoperative survival.